Bio-Thera Solutions Ltd (688177) - Cash Flow Conversion Efficiency

Latest as of June 2023: -0.054x

Based on the latest financial reports, Bio-Thera Solutions Ltd (688177) has a cash flow conversion efficiency ratio of -0.054x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-72.53 Million ≈ $-10.61 Million USD) by net assets (CN¥1.35 Billion ≈ $198.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Bio-Thera Solutions Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Bio-Thera Solutions Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Bio-Thera Solutions Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Bio-Thera Solutions Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bio-Thera Solutions Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Alphamin Res V:AFM	0.124x
Jsti Group SHE:300284	-0.038x
SINOTRANS LTD H YC 1 F:SIY	0.020x
Array Technologies Inc NASDAQ:ARRY	0.068x
Tamilnad Mercantile Bank Limited NSE:TMB	0.057x
Eit Environmental Development Group SHE:300815	0.034x
Bellring Brands LLC NYSE:BRBR	0.006x
RES.MINING UNSP.ADR/10 F:RSM0	N/A

Annual Cash Flow Conversion Efficiency for Bio-Thera Solutions Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Bio-Thera Solutions Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see 688177 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥708.09 Million ≈ $103.62 Million	CN¥-55.65 Million ≈ $-8.14 Million	-0.079x	+79.32%
2023-12-31	CN¥1.21 Billion ≈ $177.46 Million	CN¥-460.87 Million ≈ $-67.44 Million	-0.380x	-47.96%
2022-12-31	CN¥1.61 Billion ≈ $235.19 Million	CN¥-412.82 Million ≈ $-60.41 Million	-0.257x	-326.93%
2021-12-31	CN¥2.09 Billion ≈ $305.47 Million	CN¥236.27 Million ≈ $34.57 Million	0.113x	+163.40%
2020-12-31	CN¥2.01 Billion ≈ $293.48 Million	CN¥-358.04 Million ≈ $-52.39 Million	-0.179x	+81.17%
2019-12-31	CN¥630.67 Million ≈ $92.29 Million	CN¥-597.98 Million ≈ $-87.50 Million	-0.948x	-43.83%
2018-12-31	CN¥801.32 Million ≈ $117.26 Million	CN¥-528.25 Million ≈ $-77.30 Million	-0.659x	+3.20%
2017-12-31	CN¥347.55 Million ≈ $50.86 Million	CN¥-236.68 Million ≈ $-34.63 Million	-0.681x	-213.27%
2016-12-31	CN¥534.43 Million ≈ $78.20 Million	CN¥-116.18 Million ≈ $-17.00 Million	-0.217x	--

About Bio-Thera Solutions Ltd

SHG:688177 China Biotechnology

Market Cap

$1.25 Billion

CN¥8.53 Billion CNY

Market Cap Rank

#8162 Global

#2064 in China

Share Price

CN¥20.60

Change (1 day)

-0.43%

52-Week Range

CN¥20.50 - CN¥34.72

All Time High

CN¥71.90